tradingkey.logo

Aflac Inc

AFL

109.130USD

+0.430+0.40%
Close 09/12, 16:00ETQuotes delayed by 15 min
58.36BMarket Cap
23.95P/E TTM

Aflac Inc

109.130

+0.430+0.40%

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated2025-09-12

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
38 / 112
Overall Ranking
115 / 4724
Industry
Insurance

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 15 analysts
Hold
Current Rating
108.750
Target Price
-0.35%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Aflac Incorporated is a provider of supplemental health insurance products. The Company's insurance business is marketed and administered through Aflac Life Insurance Japan Ltd. (ALIJ) in Japan and through American Family Life Assurance Company of Columbus (Aflac), American Family Life Assurance Company of New York (Aflac New York), Continental American Insurance Company (CAIC), Tier One Insurance Company (TOIC) and Aflac Benefit Solutions, Inc. (ABS) in the United States. Its segments include Aflac Japan and Aflac U.S. Aflac Japan is designed to help consumers pay for medical and non-medical costs that are not reimbursed under Japan's national health insurance system. Its insurance products include cancer, medical and income support insurance, nursing care insurance, work leave insurance, whole life, GIFT and WAYS and child endowment. It designs its United States insurance products to provide supplemental coverage for people having medical or primary insurance coverage.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 23.20.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 20.72%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 20.72%.
Overvalued
The company’s latest PE is 24.47, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 378.09M shares, decreasing 2.21% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 50.54M shares of this stock.

Financial Health

Currency: USD Updated2025-09-12

The company's current financial score is 6.04, which is lower than the Insurance industry's average of 6.32. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 3.40B, representing a year-over-year decrease of 37.49%, while its net profit experienced a year-over-year decrease of 98.46%.

Score

Industry at a Glance

Previous score
6.04
Change
0

Financials

4.87

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data

Quality of Earnings

10.00

Operational Efficiency

5.67

Growth Potential

4.00

Shareholder Returns

5.65

Company Valuation

Currency: USD Updated2025-09-12

The company’s current valuation score is 5.60, which is higher than the Insurance industry's average of 4.09. Its current P/E ratio is 24.09, which is -54.14% below the recent high of 11.05 and 60.36% above the recent low of 9.55.

Score

Industry at a Glance

Previous score
6.59
Change
-0.05

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 38/112
No Data

Earnings Forecast

Currency: USD Updated2025-09-12

The company’s current earnings forecast score is 6.27, which is lower than the Insurance industry's average of 7.17. The average price target for Aflac Inc is 107.50, with a high of 124.00 and a low of 99.00.

Score

Industry at a Glance

Previous score
6.27
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 15 analysts
Hold
Current Rating
108.750
Target Price
-0.35%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

20
Total
8
Median
8
Average
Company name
Ratings
Analysts
Aflac Inc
AFL
15
Prudential Financial Inc
PRU
17
MetLife Inc
MET
17
Corebridge Financial Inc
CRBG
15
Unum Group
UNM
14
Principal Financial Group Inc
PFG
14
1
2
3
4

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated2025-09-12

The company’s current price momentum score is 9.45, which is higher than the Insurance industry's average of 8.31. Sideways: Currently, the stock price is trading between the resistance level at 112.39 and the support level at 99.69, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
7.38
Change
1.76

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(1)
Buy(4)
Indicators
Value
Direction
MACD(12,26,9)
0.022
Buy
RSI(14)
62.072
Neutral
STOCH(KDJ)(9,3,3)
82.368
Buy
ATR(14)
1.727
High Vlolatility
CCI(14)
144.742
Buy
Williams %R
7.830
Overbought
TRIX(12,20)
0.156
Sell
StochRSI(14)
100.000
Buy
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
107.534
Buy
MA10
107.237
Buy
MA20
107.200
Buy
MA50
104.060
Buy
MA100
104.354
Buy
MA200
105.257
Buy

Institutional Confidence

Currency: USD Updated2025-09-12

The company’s current institutional recognition score is 7.00, which is lower than the Insurance industry's average of 7.84. The latest institutional shareholding proportion is 70.69%, representing a quarter-over-quarter decrease of 0.18%. The largest institutional shareholder is The Vanguard, holding a total of 50.54M shares, representing 9.45% of shares outstanding, with 1.71% increase in holdings.

Score

Industry at a Glance

Previous score
7.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Japan Post Holdings Co., Ltd.
52.30M
--
The Vanguard Group, Inc.
Star Investors
51.11M
+0.02%
BlackRock Institutional Trust Company, N.A.
28.97M
-0.25%
State Street Global Advisors (US)
25.05M
+0.10%
Wells Fargo Advisors
14.79M
-2.09%
Geode Capital Management, L.L.C.
12.87M
+3.23%
BlackRock Asset Management Ireland Limited
4.28M
+3.49%
Northern Trust Investments, Inc.
4.36M
-1.03%
Dimensional Fund Advisors, L.P.
3.82M
-1.51%
Norges Bank Investment Management (NBIM)
3.38M
+0.41%
1
2

Risk Assessment

Currency: USD Updated2025-09-12

The U.S. Dollar Index is currently in a neutral state, which has a minor effect on the Insurance mixed industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The company’s current risk assessment score is 6.41, which is higher than the Insurance industry's average of 5.26. The company's beta value is 0.84. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
6.41
Change
0
Beta vs S&P 500 index
0.85
VaR
+2.09%
240-Day Maximum Drawdown
+14.90%
240-Day Volatility
+22.55%
Return
Best Daily Return
60 days
+3.43%
120 days
+5.54%
5 years
+6.57%
Worst Daily Return
60 days
-2.41%
120 days
-8.74%
5 years
-9.65%
Sharpe Ratio
60 days
+1.47
120 days
+0.20
5 years
+1.10
Risk Assessment
Maximum Drawdown
240 days
+14.90%
3 years
+17.06%
5 years
+20.43%
Return-to-Drawdown Ratio
240 days
-0.06
3 years
+1.45
5 years
+1.41
Skewness
240 days
-1.22
3 years
-0.87
5 years
-0.51
Volatility
Realised Volatility
240 days
+22.55%
5 years
+22.60%
Standardised True Range
240 days
+1.84%
5 years
+1.29%
Downside Risk-Adjusted Return
120 days
+22.86%
240 days
+22.86%
Maximum Daily Upside Volatility
60 days
+11.59%
Maximum Daily Downside Volatility
60 days
+12.03%
Liquidity
Average Turnover Rate
60 days
+0.47%
120 days
+0.43%
5 years
--
Turnover Deviation
20 days
+26.25%
60 days
+18.37%
120 days
+7.36%

Peer Comparison

Currency: USD Updated2025-09-12
Aflac Inc
Aflac Inc
AFL
6.91 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Hci Group Inc
Hci Group Inc
HCI
8.05 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
MetLife Inc
MetLife Inc
MET
8.03 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Unum Group
Unum Group
UNM
7.98 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AXIS Capital Holdings Ltd
AXIS Capital Holdings Ltd
AXS
7.98 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Arch Capital Group Ltd
Arch Capital Group Ltd
ACGL
7.89 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.

KeyAI